FDA Inspection 1094298 — Agon Pharma Private Limited

Agon Pharma Private Limited — FEI 3007481629

The FDA completed an inspection of Agon Pharma Private Limited on Jun 13, 2019 in Yawat. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 4 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jun 13, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Yawat (India)

Citations

IDCFRDescription
135821 CFR 211.100(b)SOPs not followed / documented
201221 CFR 211.188(b)Batch production and Batch Control Record Requirements
358221 CFR 211.105(a)Identification of containers, lines, equipment
430721 CFR 211.80(d)Status of Each Lot Identified

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.